Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 11, 1997, Pages 2497-2501

  Houlihan, Heather H ^a   Mercier, Renee Claude ^a   Rybak, Michael J ^a,b,c  

^a WAYNE STATE UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DETROIT RECEIVING HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENTAMICIN; METICILLIN; THROMBIN; VANCOMYCIN;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOSE CALCULATION; DOSE TIME EFFECT RELATION; DRUG EFFICACY; HUMAN; HUMAN CELL; HUMAN TISSUE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL; THROMBOCYTE;

EID: 0030685786     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.11.2497     Document Type: Article

References (35)

1. Ackerman, B. H., A. M. Vannier, and E. B. Eudy. 1992. Analysis of vancomycin time-kill studies with Staphylococcus species by using a curve stripping program to describe the relationship between concentration and pharmacodynamic response. Antimicrob. Agents Chemother. 36:1766-1769.
2. Bates, R. D., and M. C. Nahata. 1994. Once-daily administration of aminoglycosides. Ann. Pharmacother. 28:757-765.
3. Blaser, J. 1985. In-vitro model for simultaneous simulation of the serum kinetics of two drugs with different half-lives. J. Antimicrob. Chemother. 15(Suppl. A):125-130.
4. Cremeiux, A. C., B. Maziere, J. M. Vallois, M. Ottaviani, A. Azancot, A. Raffoul, A. Bouvet, J. J. Pocidalo, and C. Carbon. 1989. Evaluation of antibiotic diffusion into cardiac vegetations by quantitative autoradiography. J. Infect. Dis. 159:938-944.
5. Eliopoulos, G. M., and R. C. Moellering. 1991. Antibiotic combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, Md.
6. Faville, R. J., D. E. Zaske, E. L. Kaplan, K. Crossley, L. D. Sabath, and P. G. Quie. 1978 Staphylococcus aureus endocarditis combined therapy with vancomycin and rifampin. JAMA 240:1963-1965.
7. Francioli, P. B., and M. P. Glauser. 1993. Synergistic activity of ceftriaxone combined with netilmicin administered once daily for the treatment of experimental streptococcal endocarditis. Antimicrob. Agents Chemother. 37: 207-212.
8. Garrison, M. W., J. C. Rotschafer, and K. B. Crossley. 1989. Suboptimal effect of daptomycin in the treatment of bacteremia. South. Med. J. 82:1414-1415.
9. Gavaldà, J., P. J. Cardona, B. Almirante, J. A. Capdevila, M. Laguarda, L. Pou, E. Crespo, C. Pigrau, and A. Pahissa. 1996. Treatment of experimental endocarditis due to Enterococcus faecalis using once daily dosing regimen of gentamicin plus simulated profiles of ampicillin in human serum. Antimicrob. Agents Chemother. 40:173-178.
10. Gavaldà, J., A. Pahissa, B. Almirante, M. Laguarda, E. Crespo, L. Pou, and F. Fernández. 1995. Effect of gentamicin dosing interval on therapy of viridans streptococcal experimental endocarditis with gentamicin plus penicillin. Antimicrob. Agents Chemother. 39:2098-2103.
11. Geraci, J. E., and P. E. Hermans. 1983. Vancomycin. Mayo Clin. Proc. 58:88-91.
12. Gilbert, D. N., C. A. Wood, R. C. Kimbrough, and the Infectious Diseases Consortium of Oregon. 1991. Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. Antimicrob. Agents Chemother. 35:79-87.
13. Hatala, R., T. Dinh, and D. J. Cook. 1996. Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis. Ann. Intern. Med. 124:717-725.
14. Kaatz, G. W., S. L. Barriere, D. R. Schaberg, and R. Fekety. 1987. The emergence of resistance of ciprofloxacin during treatment of experimental Staphylococcus aureus endocarditis. J. Antimicrob. Chemother. 18:533-543.
15. Kaatz G. W., S. M. Seo, S. L. Barriere, L. M. Albrecht, and M. J. Rybak. 1991. Development of resistance to fleroxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis. Antimicrob. Agents Chemother. 35:1547-1550.
16. Kaatz, G. W., S. M. Seo, N. J. Dorman, and S. A. Lerner. 1990. Emergence of teicoplanin resistance during therapy of Staphylococcus aureus endocarditis. J. Infect. Dis. 162:103-108.
17. Kang, S. L., and M. J. Rybak. 1995. Pharmacodynamics of RP 59500 alone and in a combination with vancomycin against Staphylococcus aureus in an in vitro-infected fibrin clot model. Antimicrob. Agents Chemother. 39:1505-1511.
18. Leport, C., C. Perrone, P. Massip, P. Canton, P. Leclercq, E. Bernard, P. Lutun, J. J. Garaud, and J. L. Vilde. 1989. Evaluation of teicoplanin for the treatment of endocarditis caused by gram-positive cocci in 20 patients. Antimicrob. Agents Chemother. 33:871-876.
19. Levine, D. P., B. S. Fromm, and B. R. Reddy. 1991. Slow response to vancomycin or vancomycin plus rifampin therapy in patients with methicillin-resistant Staphylococcus aureus endocarditis. Ann. Intern. Med. 115:674-680.
20. Massanari, R. M., and S. T. Donta. 1978. The efficacy of rifampin as adjunctive therapy in selected cases of staphylococcal endocarditis. Chest 73. 371-375.
21. McGrath, B. J., S. L. Kang, G. W. Kaatz, and M. J. Rybak. 1994. Teicoplanin, vancomycin, and gentamicin bactericidal activity alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of infective endocarditis. Antimicrob. Agents Chemother. 38:2034-2040.
22. National Committee for Clinical Laboratory Standards. 1990. Approved standard. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. National Committee for Clinical Laboratory Standards, Villanova, Pa.
23. Palmer, S. M., and M. J. Rybak. 1996. Pharmacodynamics of once-or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots. Antimicrob. Agents Chemother. 40:701-705.
24. Perdikaris, G., H. Giamarellou, A. Pefanis, I. Donta, and P. Karayiannakos. 1995. Vancomycin or vancomycin plus netilmicin for methicillin-and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis. Antimicrob. Agents Chemother. 39:2289-2294.
25. Rocci, M. L., Jr., and W. J. Jusko. 1983. Lagran program version 2.1 for area and moments in pharmacokinetic analysis. Comput. Programs Biomed. 16: 203-216.
26. Rotschafer, J. C., and M. J. Rybak. 1994. Single daily dosing of aminoglycosides: a commentary. Ann. Pharmacother. 28:797-801.
27. Rybak, M. J., L. M. Albrecht, S. C. Boike, and P. H. Chandrasekar. 1990. Nephrotoxicity of vancomycin, alone and with an aminoglycoside. J. Antimicrob. Chemother. 25:679-687.
28. Rybak, M. J., E. M. Bailey, K. C. Lamp, and G. W. Kaatz. 1992. Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia. Antimicrob. Agents Chemother. 36:1109-1114.
29. Rybak, M. J., S. A. Lerner, D. P. Levine, L. M. Albrecht, P. L. McNeil, G. A. Thompson, M. T. Kenny, and L. Yuh. 1991. Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis. Antimicrob. Agents Chemother. 35:696-700.
30. Small, P. M., and H. F. Chambers. 1990. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob. Agents Chemother. 34:1227-1231.
31. Thompson, D. F., N. A. Letassy, and D. G. Thompson. 1988. Fibrin glue: a review of its preparation, efficacy, and adverse effects. Drug Intell. Clin. Pharm. 22:946-952.
32. Tuazon, C. U., M. Y. C. Lin, and J. N. Sheagren. 1978. In vitro activity of rifampin alone and in combination with nafcillin and vancomycin against pathogenic strains of Staphylococcus aureus. Antimicrob. Agents Chemother. 13:759-761.
33. Watanakunakorn, C., and C. Glotzbecker. 1974. Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides. Antimicrob. Agents Chemother. 6:802-806.
34. Watanakunakorn, C., and J. C. Guerriero. 1981. Interaction between vancomycin and rifampin against Staphylococcus aureus. Antimicrob. Agents Chemother. 19:1089-1091.
35. Watanakunakorn, C., and J. C. Tisone. 1982. Synergism between vancomycin and gentamicin or tobramycin for methicillin-susceptible or methicillin-resistant Staphylococcus aureus strains. Antimicrob. Agents Chemother. 22: 903-905.